AMPH.NASDAQAmphastar Pharmaceuticals, INC

Form 4: Amphastar EVP Zhou Rong's Tax-Related Stock Sale

Sentiment:

Insider Transaction Report

📋All filings for Amphastar Pharmaceuticals, INC
🔒Login to Follow

Amphastar Pharmaceuticals' Senior EVP, Production Center, Zhou Rong, reported a disposition of 1,124 common shares to cover tax liabilities from restricted stock unit vesting.

Summary

  • Zhou Rong, Senior EVP, Production Center at Amphastar Pharmaceuticals, Inc. (AMPH), reported a transaction on March 4, 2026.
  • 1,124 shares of common stock were disposed of at a price of $19.96 per share.
  • This disposition was to satisfy tax liability related to the vesting of restricted stock units (RSUs).
  • Following the transaction, Zhou Rong directly owns 136,919 shares.
  • Indirect ownership includes 99,668 shares held by the Zhou Family Trust and 5,000 shares held by the reporting person's spouse.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a standard tax-related disposition of shares following RSU vesting, with no implications for company performance or executive confidence.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that routine insider transactions like tax-related sales are common and typically do not signal a change in company fundamentals or executive sentiment. This transaction is specific to an individual's compensation structure.

Stakeholder Impact

  • This routine tax-related stock disposition has minimal direct impact on shareholders, employees, customers, suppliers, or creditors, as it reflects a standard compensation event for an executive.

Key Dates

DateDescription
03/04/2026Date of transaction (disposition of shares).
03/06/2026Date of filing signature.

Recommendation

hold

This Form 4 filing reports a routine tax-related disposition of shares by an executive following RSU vesting. It does not provide new information regarding the company's financial performance, strategic direction, or operational outlook that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as the underlying investment thesis remains unchanged.

Keywords

Amphastar Pharmaceuticals, AMPH, Insider Transaction, Form 4, Stock Sale, RSU Vesting, Tax Withholding, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.